The development objective of the project is to "facilitate innovation in biopharmaceutical products and medical devices that address public health priorities in India." The project will provide grant funding to support the creation of centers of excellence for validation, early stage bio-manufacturing, clinical development, training, and technology transfer. The project will provide grant funding to consortia of private, public, and academic institutions, led by cutting-edge institutions in their respective field, to accelerate the development of low-cost, select vaccines, biopharmaceuticals, diagnostics and medical devices that address public health priorities in India.
Bharatha Manju S. Haththotuwa
Lead Private Sector Specialist
Jorge A. Coarasa
Sr Economist (Health)
Biotechnology Industry Research Assistance Council
Dr. Renu Swarup
Senior Adviser, DBT and MD, BIRAC
ACCOUNTABILITY MECHANISM OF WORLD BANK
The World Bank Inspection Panel is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by a World Bank-financed project. If you submit a complaint to the Inspection Panel, they may investigate to assess whether the World Bank is following its own policies and procedures for preventing harm to people or the environment. You can contact the Inspection Panel or submit a complaint by emailing email@example.com. You can learn more about the Inspection Panel and how to file a complaint at: http://ewebapps.worldbank.org/apps/ip/Pages/Home.aspx.